US Stock MarketDetailed Quotes

TECX Tectonic Therapeutic

Watchlist

45.330
-1.030-2.22%

Close Dec 13 16:00 ET

45.330
0.0000.00%

Post 16:00 ET

668.74MMarket Cap-15.37P/E (TTM)

Tectonic Therapeutic Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q3)Sep 30, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(FY)Dec 31, 2021

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-131.15%-19.6M

-8.48M

-121.91%-27.64M

-7.79M

-12.45M

Net income from continuing operations

-76.22%-17.72M

---10.05M

-260.48%-32.18M

---10.29M

---8.93M

Operating gains losses

----

90.98%-643K

--0

---7.13M

Depreciation and amortization

14.29%424K

--371K

176.37%1.01M

--322K

--364K

Other non cash items

9.61%308K

--281K

80.15%1.23M

--269K

--680K

Change In working capital

-760.84%-4.27M

--646K

-4.18%1.84M

--1.64M

--1.92M

-Change in prepaid assets

-245.26%-828K

--570K

-102.15%-376K

---17K

---186K

-Change in payables and accrued expense

-686.95%-2.52M

--429K

54.99%3.28M

--1.92M

--2.11M

-Change in other current assets

-8,414.29%-582K

--7K

-27.27%-14K

--17K

---11K

-Change in other current liabilities

5.28%-341K

---360K

---1.05M

---280K

--0

Cash from discontinued investing activities

Operating cash flow

-131.15%-19.6M

---8.48M

-121.91%-27.64M

---7.79M

---12.45M

Investing cash flow

Cash flow from continuing investing activities

-2,085.71%-153K

-7K

1.60%-2.09M

-285K

-2.12M

Net PPE purchase and sale

-2,085.71%-153K

---7K

1.60%-2.09M

---285K

---2.12M

Cash from discontinued investing activities

Investing cash flow

-2,085.71%-153K

---7K

1.60%-2.09M

---285K

---2.12M

Financing cash flow

Cash flow from continuing financing activities

-5,414.91%-6.29M

-114K

-9.15%37.63M

-119K

41.42M

Net issuance payments of debt

-5.26%-120K

---114K

-110.88%-393K

---119K

--3.61M

Net common stock issuance

--0

----

Net preferred stock issuance

----

0.56%38.02M

--0

--37.81M

Proceeds from stock option exercised by employees

--77K

--0

100.00%4K

--0

--2K

Net other financing activities

---6.24M

----

Cash from discontinued financing activities

Financing cash flow

-5,414.91%-6.29M

---114K

-9.15%37.63M

---119K

--41.42M

Net cash flow

Beginning cash position

1,096.67%185.71M

--15.52M

1,486.38%28.65M

--44.75M

--1.81M

Current changes in cash

-202.77%-26.04M

---8.6M

-70.56%7.9M

---8.2M

--26.84M

Effect of exchange rate changes

--15K

--0

----

End cash Position

2,208.54%159.68M

--6.92M

27.58%36.55M

--36.55M

--28.65M

Free cash flow

-132.76%-19.76M

---8.49M

-103.93%-29.73M

---8.08M

---14.58M

Currency Unit

USD

Accounting Standards

US-GAAP

	(Q3)Sep 30, 2024	(Q3)Sep 30, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-131.15%-19.6M	-8.48M	-121.91%-27.64M	-7.79M	-12.45M
Net income from continuing operations	-76.22%-17.72M	---10.05M	-260.48%-32.18M	---10.29M	---8.93M
Operating gains losses	----	----	90.98%-643K	--0	---7.13M
Depreciation and amortization	14.29%424K	--371K	176.37%1.01M	--322K	--364K
Other non cash items	9.61%308K	--281K	80.15%1.23M	--269K	--680K
Change In working capital	-760.84%-4.27M	--646K	-4.18%1.84M	--1.64M	--1.92M
-Change in prepaid assets	-245.26%-828K	--570K	-102.15%-376K	---17K	---186K
-Change in payables and accrued expense	-686.95%-2.52M	--429K	54.99%3.28M	--1.92M	--2.11M
-Change in other current assets	-8,414.29%-582K	--7K	-27.27%-14K	--17K	---11K
-Change in other current liabilities	5.28%-341K	---360K	---1.05M	---280K	--0
Cash from discontinued investing activities
Operating cash flow	-131.15%-19.6M	---8.48M	-121.91%-27.64M	---7.79M	---12.45M
Investing cash flow
Cash flow from continuing investing activities	-2,085.71%-153K	-7K	1.60%-2.09M	-285K	-2.12M
Net PPE purchase and sale	-2,085.71%-153K	---7K	1.60%-2.09M	---285K	---2.12M
Cash from discontinued investing activities
Investing cash flow	-2,085.71%-153K	---7K	1.60%-2.09M	---285K	---2.12M
Financing cash flow
Cash flow from continuing financing activities	-5,414.91%-6.29M	-114K	-9.15%37.63M	-119K	41.42M
Net issuance payments of debt	-5.26%-120K	---114K	-110.88%-393K	---119K	--3.61M
Net common stock issuance	--0	--0	----	----	----
Net preferred stock issuance	----	----	0.56%38.02M	--0	--37.81M
Proceeds from stock option exercised by employees	--77K	--0	100.00%4K	--0	--2K
Net other financing activities	---6.24M	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-5,414.91%-6.29M	---114K	-9.15%37.63M	---119K	--41.42M
Net cash flow
Beginning cash position	1,096.67%185.71M	--15.52M	1,486.38%28.65M	--44.75M	--1.81M
Current changes in cash	-202.77%-26.04M	---8.6M	-70.56%7.9M	---8.2M	--26.84M
Effect of exchange rate changes	--15K	--0	----	----	----
End cash Position	2,208.54%159.68M	--6.92M	27.58%36.55M	--36.55M	--28.65M
Free cash flow	-132.76%-19.76M	---8.49M	-103.93%-29.73M	---8.08M	---14.58M
Currency Unit	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Heat List

Overall

No Data